Back

Effect of Vericiguat on Mortality in Ambulatory Patients with Heart Failure and Reduced Ejection Fraction: VICTOR Trial Prespecified Analysis

1 September 2025 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: HFrEF: pathophysiological insights Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Javed Butler

Baylor Scott & White Health, Dallas (United States of America)

8 More presentations in this session

Presentation thumbnail
Risk stratification with ultrasound markers of congestion in advanced heart failure
Professor H. Sisakian (Yerevan, AM)
Abstract Slides Video
Presentation thumbnail
Cardiac reverse remodeling induced by cardiac resynchronization therapy results in distinct changes in myocardial work when compared to guideline directed medical therapy
Doctor K. Ljung (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Endothelial dysfunction in HFrEF: investigating the role of red blood cells and guideline directed medical therapy
Doctor U. Reistam (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Impact of sacubitril valsartan on sleep apnea in heart failure patients with reduced ejection fraction (SV-SLEEP): a systematic review and meta-analysis
Doctor F. Al-Kindi (Muscat, OM)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of angiography-derived index of microcirculatory resistance in patients with dilated cardiomyopathy
Doctor T. Kawamura (Osaka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
HFrEF: pathophysiological insights

The Event

Event poster

ESC Congress 2025

1 September 2025 11:15 CET
You may be interested in
thumbnail
Congress Presentation
VICTOR: Vericiguat Global Study in Participants with Chronic Heart Failure
30 August 2025
thumbnail
Congress Presentation
Cardiovascular death: if this isn't failure, what is?
9 May 2026
thumbnail
Congress Presentation
Discussant review - VICTOR and VICTORIA
30 August 2025
thumbnail
Congress Presentation
HELIOS-B: Vutrisiran reduces all-cause mortality
17 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources